Table 2.
Response rates for lubiprostone 12 wk phase III irritable bowel syndrome with constipation studies
Lubiprostone | Placebo | P value | |
Overall responder | 17.90% | 10.10% | 0.001 |
Month 1 | 10.80% | 7.50% | 0.078 |
Month 2 | 18.20% | 11.40% | 0.003 |
Month 3 | 22.00% | 14.50% | 0.003 |